POOJA JAVIA: Open Payments
NPI 1548905326 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,584 in 108 payments from 18 companies in 2025. Trend: 2023 $2,243 · 2024 $2,117 · 2025 $2,584
Food & beverage: $2,573Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $616 |
| Janssen Biotech, Inc. | 16 | $426 |
| Regeneron Healthcare Solutions, Inc. | 6 | $263 |
| Ardelyx, Inc. | 15 | $261 |
| Aimmune Therapeutics, Inc. | 5 | $170 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $136 |
| Novo Nordisk Inc | 3 | $129 |
| Madrigal Pharmaceuticals | 4 | $110 |
| Daiichi Sankyo Inc. | 4 | $72 |
Products named: TREMFYA, IBSRELA, SKYRIZI, DUPIXENT, ZENPEP, RINVOQ, XIFAXAN, ENTYVIO.
Industry payments across GA — which companies pay providers there.
